Andog, Anna Marie .

HRN: 22-06-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2023
CEFUROXIME 1.5GM (VIAL)
05/17/2023
05/24/2023
IV
1.5 Gm
Q8
Anemia Severe Sec To PostPartum Hemorrhage; G3P3 (3003)
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: